Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Plant Grow Regul 78:5767
What if there were a gentler option that worked with your body's own biology
Ramsay EE, Dilda PJ (2014) Glutathione S-conjugates as prodrugs to target drug-resistant tumors
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive weekly subcutaneous injections of either CagriSema or Tirzepatide, with a dose escalation period followed by maintenance dosing Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
US$ 29.72
US$ 28.25
US$ 29.82
US$ 22.39
US$ 24.01
US$ 29.12
US$ 20.74
